Name | Cvs Pharmacy #07982 |
---|---|
Organization Name | Holiday Cvs Llc |
Location | 520 S Federal Hwy, Boca Raton, Florida 33432 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (561) 362-3240 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
KaloBios Pharmaceuticals, Inc. (KaloBios) today announced that it is offering to sell shares of its common stock in an underwritten public offering.
In influencing the trajectory of the pandemic stage of an emerging pathogen, a population's susceptibility to a novel disease is more influential than climate factors like humidity.
PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today reported financial results for the three-month period ended March 31, 2010.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains on track for a regulatory decision by mid-2011.
A team led by Afsaneh Gaillard (Inserm Unit 1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers), in collaboration with the Institute of Interdisciplinary Research in Human and Molecular Biology (IRIBHM) in Brussels, has just taken an important step in the area of cell therapy: repairing the cerebral cortex of the adult mouse using a graft of cortical neurons derived from embryonic stem cells.
› Verified 9 days ago
NPI Number | 1134223019 |
Organization Name | HOLIDAY CVS LLC |
Doing Business As | CVS PHARMACY 07982 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 520 S Federal Hwy, Boca Raton, FL 33432 |
Phone Number | 561-362-3240 |
News Archive
KaloBios Pharmaceuticals, Inc. (KaloBios) today announced that it is offering to sell shares of its common stock in an underwritten public offering.
In influencing the trajectory of the pandemic stage of an emerging pathogen, a population's susceptibility to a novel disease is more influential than climate factors like humidity.
PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today reported financial results for the three-month period ended March 31, 2010.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains on track for a regulatory decision by mid-2011.
A team led by Afsaneh Gaillard (Inserm Unit 1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers), in collaboration with the Institute of Interdisciplinary Research in Human and Molecular Biology (IRIBHM) in Brussels, has just taken an important step in the area of cell therapy: repairing the cerebral cortex of the adult mouse using a graft of cortical neurons derived from embryonic stem cells.
› Verified 9 days ago
News Archive
KaloBios Pharmaceuticals, Inc. (KaloBios) today announced that it is offering to sell shares of its common stock in an underwritten public offering.
In influencing the trajectory of the pandemic stage of an emerging pathogen, a population's susceptibility to a novel disease is more influential than climate factors like humidity.
PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today reported financial results for the three-month period ended March 31, 2010.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains on track for a regulatory decision by mid-2011.
A team led by Afsaneh Gaillard (Inserm Unit 1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers), in collaboration with the Institute of Interdisciplinary Research in Human and Molecular Biology (IRIBHM) in Brussels, has just taken an important step in the area of cell therapy: repairing the cerebral cortex of the adult mouse using a graft of cortical neurons derived from embryonic stem cells.
› Verified 9 days ago
Integra Medical Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 399 Camino Gardens Blvd, Boca Raton, Florida 33432 Phone: (561) 440-8550 | |
Boca Medical Supply Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 620 Glades Rd, Boca Raton, Florida 33431 Phone: (561) 368-7430 | |
Boca Medical Supply Llc Type: Medicare Supplier Location: 1307 W Palmetto Park Rd, Boca Raton, Florida 33486 Phone: (561) 368-7430 | |
Publix Pharmacy #0428 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3003 Yamato Rd, Boca Raton, Florida 33434 Phone: (561) 998-1652 | |
Publix Pharmacy #1361 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7060w Palmetto Park Rd, Boca Raton, Florida 33433 Phone: (561) 338-4785 |